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Abstract:     Two new triterpenoids, octanordammar-1,11,13(17)-trien-17-ol-3,16-dione (1) and lup-12-en-15α,
19β-diol-3,11-dioxo-28-oic acid (4), as well as 13 known compounds were isolated from the roots of Sanguisorba
officinalis L. (Rosaceae). Their structures were determined using spectroscopic methods.
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Radix Sanguisorbae, the roots of Sanguisorba
officinalis L. (Rosaceae) distributed in the northern part
of China, has been used as a traditional Chinese medi-
cine for the treatment of burns, scalds, and internal hem-
orrhage (Chinese Pharmacopoeia Committee 2000).
Previously, hydrolysable tannins, triterpene glycosides,
and some other compounds were characterized from
the plant (Zheng et al. 1997; Mimaki et al. 2001). In
continuation of our search for pharmacologically and
structurally interesting substances from traditional Chi-
nese medicines, we investigated the chemical com-
pounds of Radix Sanguisorbae to afford two new
triterpenoids (1 and 4; Fig. 1), together with 13 known
compounds that were identified as methyl 3-O-methyl-
gallate (2; Wang et al. 1998), quercetin (3), 3,4′-O-
dimethylellagic acid (5; Satõ 1987), 3β-O-α-L-
arabinopyranosyl-19α-hydroxyurs-12-en-28-oic acid
(6; Cheng and Cao 1992), gallic acid (7; Liu et al. 2003),
catechin (8), 3, 3′, 4′-O-trimethylellagic acid (9; Sinha
et al. 1999), 3, 3′, 4′-O-trimethylellagic acid 4-O-β-D-
xyloside (10; Sinha et al. 1999), 3β,19α-dihydroxyurs-
12-en-28-oic acid 28-β-D-glucopyranoside (11; Cheng
and Cao 1992), methyl 4, 5-O-dimethyl-gallate 3-O-α-
D-glucopyranoside (12; Chen et al. 1999), 3,4′-O-
dimethylellagic acid 4-O-β-D-xyloside (13; Sinha et al.
1999), 3β-O-α-L-arabinopyranosyl-19α-hydroxyurs-
12-en-28-oic acid 28-β-D-glucopyranoside (14; Cheng
and Cao 1992), and 3, 3′, 4′-O-trimethylellagic acid 4-
O-α-D-glucopyranoside (15; Hillis and Yazaki 1973).
Among these compounds, quercetin (3), gallic acid (7),
and catechin (8) have some bioactivities; also, the other
compounds are almost all derivatives of gallic acid,
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Fig. 1.    Structures of compounds 1 and 4
http://www.blackwell-synergy.com
http://www.chineseplantscience.com
Journal of Integrative Plant Biology (Formerly Acta Botanica Sinica)    Vol. 47    No. 2    2005252
ellagic acid, or ursolic acid, which have some pharma-
ceutical activity (Zhou et al. 2003).
1    Results and Discussion
Compound 1 was obtained as a white powder. The
HRESI-MS of 1 indicated a protonated molecular ion
peak at m/z 341.211 2 [M+H]+ requiring a molecular
formula C22H28O3. The IR absorption bonds at 3 294,
1 681, and 1 666 cm–1 indicated the presence of
hydroxyl and α,β-unsaturated carbonyl groups. The
1H-NMR spectrum exhibited resonances for two 1, 2-
disubsituted double bonds (δH 7.41 and 5.80; δH 6.29
and 6.72) and five tertiary methyl groups (δH 1.12,
1.07, 1.03, 1.00, and 0.66). With the aid of the DEPT
experiment, the 13C-NMR spectrum (Table 1) showed
five CH3, three CH2, six CH and eight C signals, in-
cluding two α,β-unsaturated carbonyls (δC 204.3,
201.5) and three double bonds (δC 159.5, 146.2,
Table 1    1H- and 13C-NMR data for compounds 1 (DMSO-d6) and 4 (pyridine-d5)
Position
                                         1                                   4
δH δC δH δC
  1 7.41 d (10 Hz) 159.5 d 1α: 1.53 m 40.1 t
1β: 3.22 m
  2 5.80 d (10 Hz) 125.4 d 2α: 2.39 m 34.4 t
2β: 2.63 m
  3 204.3 s 216.0 s
  4  44.8 s  47.7 s
  5 1.71 m  53.1 d 1.43 m  55.2 d
  6 1.62 m  19.0 t 1.43 m  19.3 t
  7 1.53 m, 1.38 m  32.4 t 7α: 2.63 m 34.4 t
7β: 2.39 m
  8  40.4 s  47.3 s
  9 2.32 m  49.2 d 2.88 s  61.0 d
10  39.3 s  37.2 s
11 6.29 brd (10 Hz) 132.9 d 199.7 s
12 6.72 dd (10, 3 Hz) 122.1 d 6.22 s 133.5 d
13 145.9 s 166.9 s
14  43.8 s  50.3 s
15 2.30 d (18 Hz), 1.79 d (18 Hz)  42.5 t 4.86 dd (11, 5 Hz)  68.0 d
16 201.5 s 16α: 3.54 t (11 Hz) 36.7 t
16β: 2.54 dd (11, 5 Hz)
17 146.2 s  47.1 s
18 3.12 s  55.6 d
19  72.6 s
20 1.41 m  42.0 d
21 21α: 2.29 m 36.1 t
21β: 2.14 m
22 22α: 1.96 m
22β: 2.16 m  37.6 t
23 1.07 s  27.7 q 1.11 s  26.5 q
24 1.00 s  21.6 q 0.99 s  21.4 q
25 1.12 s  21.5 q 1.30 s  15.8 q
26 0.66 s  16.6 q 1.38 s  19.5 q
27 1.03 s  24.5 q 2.11 s  16.7 q
28 180.1 s
29 1.03 d (7 Hz)  16.4 q
30 1.37 d (5 Hz)  26.5 q
OH 9.45 s
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145.9, 132.9, 125.4, and 122.1). The compound was
suggested to be an octanordammarane-type triterpene
(Yamashita et al. 1998) and the HMBC (Fig. 2) corre-
lations of the five individual tertiary methyl signals on
rings A–D (Me-23, 24, 25, 26, and 27) firmly estab-
lished the linkages of these partial structural units.
Furthermore, the 1H-1H COSY spectrum of 1 estab-
lished the proton sequences from H-1 to H-2, H-5 to
H2-7, and H-9 to H-12. The signals of C-1, C-2, C-13,
and C-17 appeared at δC 159.5, 125.4, 145.9, and
146.2, respectively, due to the presence of two carbo-
nyls at C-3 and C-16. The hydroxy was positioned at
C-17 from the HMBC correlations of OH with C-16
and C-17. Thus, compound 1 was elucidated to be
octanordammar-1,11,13(17)-trien-17-ol-3,16-dione.
Compound 4 was obtained as a colorless needle. The
molecular formula of compound 4 was determined to
be C30H44O6 by HRESI-MS (m/z 523.304 6 [M+Na]+).
The NMR spectra (Table 1) of 4 permitted its initial
assignment as a pentacyclic triterpenoid, because there
are 30 carbon signals, including seven methyl groups
(δH 2.11, 1.38, 1.37, 1.30, 1.11, 1.03, and 0.99). The
IR absorption showed hydroxy, α,β-unsaturated
carbonyl, and double bond absorptions at 3 436, 1 695,
1 646, and 1 626 cm–1. Using one- and two-dimen-
sional NMR analysis, 4 was presumed to be a lupane-
type triterpenoid with two carbonyls, one double bond,
and one carboxyl group. In the HMBC (Fig. 3) spectrum,
the long range correlations of C-3 to Hα,β-1, Hα,β-2,
Me-23, and Me-24, and C-11 to H-9 revealed a ketone
and a conjunctive ketone at C-3 (δC 216.0) and C-11
(δC 199.7). The carboxyl group was positioned at C-28
from the major HMBC correlations of C-28 with
Hα,β-16 and H-18. Based on HMBC correlations of
C-15 with Hα,β-16 and Me-27, and C-19 with H-18,
Me-29, and Me-30, two hydroxy groups were assigned
at C-15 and C-19. Thus, the NOESY correlations (Fig.
3) of H-15 with Me-26 and Hβ-16 and; Hα-18 with H-
20 and Me-30 showed that hydroxy groups at C-15
and C-19 are α- and β-oriented, respectively. These
spectroscopic data corroborated the structure of 4 as
lup-12-en-15α,19β-diol-3,11-dioxo-28-oic acid.
2    Experimental
2.1    General experimental procedures
Optical rotation was read on a Perkin-Elmer 341
polarimeter (Perkin-Elmer Corporation, Wellesley, MA,
USA) at 589 nm. The IR and UV spectra were mea-
sured on Perkin-Elmer Fourier transform infrared spec-
troscopy (FTIR) and Lambda 35 spectrometers (Perkin-
Elmer Corporation, Wellesley, MA, USA), respectively.
The NMR spectra were obtained on a Bruker Avance
600 spectrometer (Bruker BioSpin Corporation,
Fallanden, Switzerland). Chemical shifts were given in
δ (ppm) with TMS as an internal standard; coupling
constants were reported in Hz. The HRESI-MS was
acquired on a Bruker BioTOFQ spectrometer (Bruker
BioSpin Corporation, Fallanden, Switzerland). The ESI-
MS was recorded on Finnigan LCQDECA spectrometer
(Finnigan Corporation, San Joe, CA, USA). Column
chromatography was performed on silica gel (Marine
Chemical Factory, Qingdao, China) and ODS silica gel
(25×2.5 cm; Cosmosil 75 C18-OPN (Nacalai Tesque
Corporation, Kyoto, Japan)).
2.2    Plant materials
The roots of Sanguisorba officinalis L. were pro-
vided by Chengdu Di-Ao Pharmaceutical Co. Ltd.
(Chengdu, China). Authentic samples of quercetin and
catechin were purchased from Shanghai Chemical Re-
agent Factory No. 2 (Shanghai, China).Fig. 2.    Selected HMBC correlations for compound 1.
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2.3    Extraction and isolation
The dried roots of the plant (20 kg) were extracted
with 95% EtOH three times at room temperature. After
removal of EtOH, the remaining aqueous solution was
filtered and then extracted with EtOAc (3 L) and
n-butanol (3 L) to yield two corresponding portions.
The EtOAc extracts (300 g) were chromatographed over
silica gel (160–200 mesh, 1.6 kg) with eluents of in-
creasing polarity (petrol/acetone (20:1, 15:1, 10:1, 8:1,
6:1, 4:1, and 1:1), each 5 000 mL) to afford fractions
1–6 according to TLC analysis. Fraction 1 (0.35 g) was
further purified by silica gel column chromatography
(CC; 15 g) eluting with petrol/acetone (8:1, 300 mL) to
give compound 1 (15 mg). Fraction 2 (2 g) was applied
to an ODS silica gel column with MeOH/H2O (1:3) to
give compound 2 (125 mg). Fraction 3 (2 g) was sepa-
rated by the same ODS silica gel column using MeOH/
H2O (2:3) into compounds 3 (20 mg) and 4 (10 mg).
Compound 5 (200 mg) was obtained from fraction 4 (4
g) by recrystallization and the mother liquid (2 g) was
further purified on a silica gel (100 g) column with
petrol/acetone (5:1, 1 500 mL) as the eluent to furnish
compound 6 (20 mg). Fraction 5 (1 g) was subjected
to silica gel (40 g) CC eluted with CHCl3/MeOH (10:1,
1 000 mL) to give compound 7 (20 mg). Compound 8
(40 mg) was obtained from fraction 6 (4 g) by CC on a
silica gel (200 g) with CHCl3/MeOH (10:1, 2 000 mL).
The n-butanol extracts (320 g) were separated by CC
on silica gel (160–200 mesh, 1.2 kg) with gradients of
CHCl3/MeOH (30:1, 20:1, 10:1, 8:1, 6:1, 4:1, and 1:1,
each 5 000 mL) giving fractions 7–12 according to their
TLC pattern. Fractions 7 and 8 were recrystallized,
respectively, with MeOH to give compounds 9 (900
mg) and 10 (80 mg). Fraction 9 (0.4 g) was applied to
an ODS silica gel column with MeOH/H2O (2:5) to give
compound 11 (50 mg). Fraction 10 (50 mg) was sub-
jected to silica gel (2 g) CC eluted with CHCl3/MeOH
(20:1, 300 mL) to furnish compound 12 (5 mg). Com-
pound 13 (22 mg) was obtained from fraction 11 (7 g)
by recrystallization and the mother liquid (5 g) was fur-
ther purified on a silica gel (200 g) column with CHCl3/
MeOH (10:1, 1 500 mL) as the eluent to yield com-
pound 14 (1.1 g). Fraction 12 was recrystallized with
MeOH to supply compound 15 (20 mg).
2.4    Identification
Compound 1    White powder; HRESI-MS m/z:
341.211 2 [M+H]+ (calcd. for C22H29O3, 341.211 6);
ESI-MS m/z: 341[M+H]+, 339[M–H]–; mp 267–269 °C;
[α]20D  : –40° (c 0.1, CHCl3); IR (KBr) νmax: 3 294, 1 681,
1 666, 1 635 cm–1; UV (CHCl3) λmax (lgε): 302 (4.28),
240 (3.88) nm; for 1H- and 13C-NMR, see Table 1.
Compound 2   White powder; ESI-MS m/z: 199
[M+H]+, 197[M–H]–; 1H-NMR (CDCl3) δ: 3.88 (s,
OMe-1), 7.34 (s, H-2), 3.93 (s, OMe-3), 5.90 (s, OH-
4), 5.55 (s, OH-5), 7.21 (s, H-6); 13C-NMR (CDCl3) δ:
122.0 (C-1), 105.0 (C-2), 143.6 (C-3), 137.0 (C-4),
146.6 (C-5), 111.2 (C-6), 167.1 (CO), 52.3 (OMe-1),
56.5 (OMe-3).
Fig. 3.    Selected HMBC (→) and NOESY (↔) correlations for compound 4.
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Compound 3    Yellow powder; ESI-MS m/z: 603
[2M–H]–, 301 [M–H]–; mp 312–313 °C. Compound 3
was identified by comparison of the mixed melting point
and Rf  value (on TLC, CHCl3:MeOH=5:1, Rf=0.5) with
an authentic sample.
Compound 4    Colorless needle; HRESI-MS m/z:
523.304 6 [M+Na]+ (calcd. for C30H44O6Na, 523.303 5);
ESI-MS m/z: 501[M+H]+, 499[M–H]–; mp 264–266 °C;
[α]20D: 0° (c 0.1, MeOH); IR (KBr) νmax: 3 436, 1 695,
1 646, 1 626 cm–1; UV (MeOH) λmax (lgε): 260 (4.14)
nm; for 1H- and 13C-NMR, see Table 1.
Compound 5    White powder; ESI-MS m/z: 331
[M+H]+, 329 [M–H]–; 1H-NMR (DMSO-d6) δ: 10.7
(brs, OH), 4.05 (3H, s, OMe-3), 7.45 (1H, s, H-5),
3.93 (3H, s, OMe-4′), 7.43 (1H, s, H-5′); 13C-NMR
(DMSO-d6) δ: 111.6 (C-1), 141.7 (C-2), 140.2 (C-3),
152.6 (C-4), 111.4 (C-5), 112.9 (C-6), 158.8 (C-7),
107.0 (C-1′), 140.6 (C-2′), 135.7 (C-3′), 149.9 (C-4′),
106.8 (C-5′), 113.7 (C-6′), 158.9 (C-7′), 61.1 (OMe-
3), 56.7 (OMe-4′).
Compound 6    Colorless needle; ESI-MS m/z: 627
[M+Na]+, 603 [M–H]–; mp 219–221 °C; 1H-NMR
(pyridine-d5) δ: 3.33 (dd, J=12, 4 Hz, H-3), 5.59 (brs,
H-12), 3.04 (s, H-18), 1.43, 1.26, 1.08, 0.94, 0.86 (s,
Me×5), 1.73 (s, H-29), 1.11 (d, J=7 Hz, H-30), 4.76
(d, J=7 Hz, ara-1), 4.41 (t, J=8 Hz, ara-2), 4.15 (dd,
J=9, 3 Hz, ara-3), 3.83 (m, ara-4), 4.30 (m, ara-5);
13C-NMR (pyridine-d5) δ: 38.9 (t, C-1), 26.8 (t, C-2),
88.9 (d, C-3), 39.7 (s, C-4), 56.0 (d, C-5), 18.7 (t,
C-6), 33.6 (t, C-7), 40.5 (s, C-8), 47.8 (d, C-9), 37.1
(s, C-10), 24.1 (t, C-11), 128.1 (d, C-12), 140.0 (s,
C-13), 42.2 (s, C-14), 29.4 (t, C-15), 26.5 (t, C-16),
48.4 (s, C-17), 54.7 (d, C-18), 72.8 (s, C-19), 42.5 (d,
C-20), 27.1 (t, C-21), 38.5 (t, C-22), 28.4 (q, C-23),
17.3 (q, C-24), 15.6 (q, C-25), 17.0 (q, C-26), 24.8 (q,
C-27), 180.7 (s, C-28), 27.3 (q, C-29), 16.9 (q, C-30),
107.6 (d, ara-1), 73.0 (d, ara-2), 74.7 (d, ara-3), 69.6
(d, ara-4), 66.8 (d, ara-5).
Compound 7    Colorless needle; ESI-MS m/z: 169
[M–H]–; mp 253–255 °C; 1H-NMR (DMSO-d6) δ: 12.2
(COOH), 9.18 (s, OH-3, 5), 8.82 (s, OH-4), 6.90 (s,
H-2, 6); 13C-NMR (DMSO-d6) δ: 121.0 (C-1), 109.3
(C-2), 146.0 (C-3), 138.6 (C-4), 146.0 (C-5), 109.3
(C-6), 168.1 (COOH).
Compound 8    Yellow powder; ESI-MS m/z: 313
[M+Na]+, 289 [M–H]–; mp 160–161 °C; [α]20D: +12° (c
0.1, CHCl3). Compound 8 was identified by compari-
son of the mixed melting point and Rf value (on TLC,
CHCl3:MeOH=5:1, Rf=0.5) with an authentic sample.
Compound 9    Yellow powder; ESI-MS m/z: 345
[M+H]+, 343 [M–H]–; 1H-NMR (pyridine-d5) δ: 4.17
(3H, s, OMe-3), 7.80 (1H, s, H-5), 4.12 (3H, s, OMe-
3′), 3.83 (3H, s, OMe-4′), 8.02 (1H, s, H-5′); 13C-NMR
(pyridine-d5) δ: 114.3 (C-1), 142.3 (C-2), 141.7 (C-3),
154.5 (C-4), 111.8 (C-5), 113.1 (C-6), 159.2 (C-7),
113.8 (C-1′), 141.9 (C-2′), 141.3 (C-3′), 154.2 (C-4′),
108.0 (C-5′), 112.8 (C-6′), 159.1 (C-7′), 61.5 (OMe-
3), 61.2 (OMe-3′), 56.5 (OMe-4′).
Compound 10    White powder; ESI-MS m/z: 499
[M+Na]+, 477 [M+H]+; 1H-NMR (DMSO-d6) δ: 4.08
(s, OMe-3), 7.74 (s, H-5), 4.03 (s, OMe-3′), 3.98 (s,
OMe-4′), 7.51 (s, H-5′), 5.16 (d, J=7 Hz, xyl-1); 13C-
NMR (DMSO-d6) δ: 113.7 (C-1), 141.9 (C-2), 141.2
(C-3), 154.4 (C-4), 112.1 (C-5), 112.6 (C-6), 158.4
(C-7), 112.8 (C-1′), 141.2 (C-2′), 141.0 (C-3′), 151.7
(C-4′), 107.6 (C-5′), 112.3 (C-6′), 158.3 (C-7′), 61.8
(OMe-3), 61.4 (OMe-3′), 56.6 (OMe-4′), 101.8 (xyl-
1), 73.1 (xyl-2), 76.2 (xyl-3), 69.3 (xyl-4), 65.9 (xyl-
5).
Compound 11    White powder; ESI-MS m/z: 657
[M+Na]+, 471 [M–H]–; 1H-NMR (pyridine-d5) δ: 3.41
(m, H-3), 5.56 (brs, H-12), 2.93 (s, H-18), 1.40, 1.26,
1.21, 1.03, 0.95 (s, Me×5), 1.68 (s, H-29), 1.05 (d,
J=6 Hz, H-30), 6.31 (d, J=8 Hz, glc-1), 4.23 (t, J=8
Hz, glc-2), 4.30 (t, J=8 Hz, glc-3), 4.36 (t, J=8 Hz, glc-
4), 4.05 (m, glc-5), 4.05 (m, glc-6); 13C-NMR (pyridine-
d5) δ: 39.1 (t, C-1), 28.1 (t, C-2), 79.2 (d, C-3), 39.4
(s, C-4), 55.9 (d, C-5), 19.0 (t, C-6), 33.6 (t, C-7),
40.5 (s, C-8), 47.8 (d, C-9), 37.3 (s, C-10), 24.1 (t,
C-11), 128.4 (d, C-12), 139.3 (s, C-13), 42.1 (s, C-
14), 29.2 (t, C-15), 26.1 (t, C-16), 48.6 (s, C-17),
54.4 (d, C-18), 72.6 (s, C-19), 42.1 (d, C-20), 26.7 (t,
C-21), 37.7 (t, C-22), 28.8 (q, C-23), 17.4 (q, C-24),
15.7 (q, C-25), 16.7 (q, C-26), 24.5 (q, C-27), 176.9
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(s, C-28), 27.0 (q, C-29), 16.5 (q, C-30), 95.8 (d, glc-
1), 74.0 (d, glc-2), 78.9 (d, glc-3), 71.2 (d, glc-4),
78.2 (d, glc-5), 62.3 (t, glc-6).
Compound 12    White powder; ESI-MS m/z: 397
[M+Na]+, 213 [M–161]+; 1H-NMR (pyridine-d5) δ:
4.00 (s, OMe-1), 8.11 (s, H-2), 3.76 (s, OMe-4), 3.72
(s, OMe-5), 7.51 (s, H-6), 5.75 (d, J=5 Hz, glc-1),
4.09–4.54 (m, glc-2–5); 13C-NMR (pyridine-d5) δ:
125.9 (C-1), 112.0 (C-2), 152.1 (C-3), 143.9 (C-4),
153.9 (C-5), 108.2 (C-6), 166.6 (CO), 52.1 (OMe-1),
61.0 (OMe-4), 56.1 (OMe-5), 102.9 (glc-1), 75.0
(glc-2), 79.1 (glc-3), 71.1 (glc-4), 78.7 (glc-5), 62.3
(glc-6).
Compound 13    White powder; ESI-MS m/z: 485
[M+Na]+, 461 [M–H]–; 1H-NMR (DMSO-d6) δ: 4.02
(s, OMe-3), 7.68 (s, H-5), 3.98 (s, OMe-4′), 7.60 (s,
H-5'), 5.00 (d, J=8 Hz, xyl-1); 13C-NMR (DMSO-d6)
δ: 114.8 (C-1), 142.0 (C-2), 141.5 (C-3), 154.9 (C-4),
112.2 (C-5), 113.5 (C-6), 159.2 (C-7), 113.5 (C-1′),
142.0 (C-2′), 136.8 (C-3′), 147.9 (C-4′), 108.1 (C-5′),
113.5 (C-6′), 159.0 (C-7′), 61.9 (OMe-3), 57.3
(OMe-4′), 103.4 (xyl-1), 73.6 (xyl-2), 76.1 (xyl-3),
69.9 (xyl-4), 66.5 (xyl-5).
Compound 14    White powder; ESI-MS m/z: 789
[M+Na]+, 603 [M−163]−; 1H-NMR (pyridine-d5) δ:
3.30 (dd, J=12, 4 Hz, H-3), 5.53 (br, H-12), 2.91 (s,
H-18), 1.37, 1.24, 1.17, 0.95, 0.90 (s, Me×5), 1.68 (s,
H-29), 1.05 (d, J=7 Hz, H-30), 4.75 (d, J=7 Hz, ara-1),
4.47−4.02 (m, ara-2–4), 3.80 (d, J=10 Hz, ara-5), 6.29
(d, J=8 Hz, glc-1), 4.47–4.02 (m, glc-2−6); 13C-NMR
(pyridine-d5) δ: 38.9 (t, C-1), 26.7 (t, C-2), 88.7 (d,
C-3), 39.5 (s, C-4), 55.9 (d, C-5), 18.7 (t, C-6), 33.5
(t, C-7), 40.5 (s, C-8), 47.7 (d, C-9), 36.9 (s, C-10),
24.0 (t, C-11), 128.4 (d, C-12), 139.2 (s, C-13), 42.1
(s, C-14), 29.2 (t, C-15), 26.1 (t, C-16), 48.6 (s,
C-17), 54.4 (d, C-18), 72.6 (s, C-19), 42.1 (d, C-20),
26.1 (t, C-21), 37.7 (t, C-22), 28.2 (q, C-23), 17.4 (q,
C-24), 15.6 (q, C-25), 16.9 (q, C-26), 24.6 (q, C-27),
176.9 (s, C-28), 27.0 (q, C-29), 16.7 (q, C-30), 107.5
(d, ara-1), 72.9 (d, ara-2), 74.6 (d, ara-3), 69.5 (d, ara-
4), 66.7 (d, ara-5), 95.8 (d, glc-1), 74.1 (d, glc-2),
78.9 (d, glc-3), 71.2 (d, glc-4), 79.2 (d, glc-5), 62.3 (t,
glc-6).
Compound 15    Colorless needle; ESI-MS m/z: 507
[M+H]+, 345 [M–161]+; mp 264–266 °C; 1H-NMR
(DMSO-d6) δ: 4.05 (s, OMe-3), 7.63 (s, H-5), 4.04 (s,
OMe-3′), 3.99 (s, OMe-4′), 7.54 (s, H-5′), 5.32 (J=5
Hz, glc-1), 2.08–1.80 (m, glc-2−5), 3.21 (m, glc-6).
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